loading

Verrica Pharmaceuticals Inc Aktie (VRCA) Neueste Nachrichten

pulisher
Jan 10, 2026

Will Verrica Pharmaceuticals Inc. stock see insider buyingTrade Analysis Report & High Win Rate Trade Alerts - ulpravda.ru

Jan 10, 2026
pulisher
Jan 09, 2026

Verrica Doses First Patient in Phase 3 Wart Trial, Eyes Major Label Expansion - MyChesCo

Jan 09, 2026
pulisher
Jan 08, 2026

Why Verrica Pharmaceuticals Inc. stock is favored by top institutionsJuly 2025 Snapshot & Free Safe Entry Trade Signal Reports - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Verrica Pharmaceuticals Inc. (1NE) stock outperform benchmarks2025 Major Catalysts & Accurate Trade Setup Notifications - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Verrica doses first patient in phase 3 trial for common wart treatment - Investing.com Nigeria

Jan 08, 2026
pulisher
Jan 07, 2026

First Patient Dosed in Phase 3 VP-102 Common Warts Program - Dermatology Times

Jan 07, 2026
pulisher
Jan 07, 2026

Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating By Investing.com - Investing.com Nigeria

Jan 07, 2026
pulisher
Jan 07, 2026

Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating - Investing.com

Jan 07, 2026
pulisher
Jan 07, 2026

Verrica Pharmaceuticals announces first patient dosed in phase 3 program - MarketScreener

Jan 07, 2026
pulisher
Jan 07, 2026

Verrica Pharmaceuticals (VRCA) Begins Phase 3 Trials for Common Warts Treatment - GuruFocus

Jan 07, 2026
pulisher
Jan 07, 2026

New wart treatment enters Phase 3 testing for 22M U.S. patients - Stock Titan

Jan 07, 2026
pulisher
Jan 07, 2026

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts - Sahm

Jan 07, 2026
pulisher
Jan 05, 2026

Verrica Pharmaceuticals adds Caligan Partner to board - MSN

Jan 05, 2026
pulisher
Jan 02, 2026

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Short Interest Update - Defense World

Jan 02, 2026
pulisher
Dec 30, 2025

Short Interest in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Decreases By 26.2% - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants - Investing.com Canada

Dec 30, 2025
pulisher
Dec 30, 2025

Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants By Investing.com - Investing.com South Africa

Dec 30, 2025
pulisher
Dec 30, 2025

Verrica Pharmaceuticals Adds Caligan Partner to Board - TipRanks

Dec 30, 2025
pulisher
Dec 30, 2025

Verrica Pharmaceuticals Appoints New Director - TradingView — Track All Markets

Dec 30, 2025
pulisher
Dec 30, 2025

Verrica Pharmaceuticals Inc. Appoints Charles Frantzreb as Director, Effective December 26, 2025 - MarketScreener

Dec 30, 2025
pulisher
Dec 28, 2025

Can Verrica Pharmaceuticals Inc. stock reach $100 price targetHigh Yield Income Stocks & Low Cost Portfolio Tips - bollywoodhelpline.com

Dec 28, 2025
pulisher
Dec 24, 2025

Verrica Pharmaceuticals (VRCA) Stock Price, Quote, News & History - Benzinga

Dec 24, 2025
pulisher
Dec 21, 2025

Verrica Pharmaceuticals upgraded to buy from hold at Brookline - MSN

Dec 21, 2025
pulisher
Dec 20, 2025

Gains Report: Can Verrica Pharmaceuticals Inc. stock reach $100 price targetJuly 2025 Reactions & Entry Point Confirmation Signals - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Is Verrica Pharmaceuticals Inc. stock a safe buy before earningsTrade Analysis Report & AI Optimized Trading Strategy Guides - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Will Verrica Pharmaceuticals Inc. stock pay special dividendsQuarterly Performance Summary & AI Powered Market Entry Strategies - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Can Verrica Pharmaceuticals Inc. stock surprise with earnings upsideJuly 2025 Outlook & Verified Swing Trading Watchlists - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Verrica Pharmaceuticals (FRA:1NE0) EV-to-OCF : -4.47 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025
pulisher
Dec 19, 2025

Can Verrica Pharmaceuticals Inc. stock weather global recessionJuly 2025 Chart Watch & Smart Investment Allocation Tips - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Verrica Pharmaceuticals Inc. stock supported by innovation pipelineJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Verrica Pharmaceuticals Inc. stock a buy on dipsJuly 2025 Highlights & AI Powered Trade Plan Recommendations - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Will Verrica Pharmaceuticals Inc. (1NE) stock boost dividends furtherMarket Sentiment Review & Reliable Entry Point Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Rating Increased to Buy at Brookline Capital Management - Defense World

Dec 19, 2025
pulisher
Dec 19, 2025

Brookline Capital upgrades Verrica Pharmaceuticals (VRCA) - MSN

Dec 19, 2025
pulisher
Dec 18, 2025

Aug Drivers: Will Verrica Pharmaceuticals Inc. stock see insider buyingMarket Sentiment Review & Weekly Top Gainers Alerts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Is Verrica Pharmaceuticals Inc. (1NE) stock undervalued after correction2025 Sector Review & Verified Momentum Stock Alerts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Stock Rating Upgraded by Brookline Capital Management - MarketBeat

Dec 18, 2025
pulisher
Dec 18, 2025

Verrica Pharmaceuticals (VRCA) Receives Upgrade from Brookline C - GuruFocus

Dec 18, 2025
pulisher
Dec 18, 2025

Verrica Pharmaceuticals stock upgraded to Buy by Brookline on pipeline potential - Investing.com Nigeria

Dec 18, 2025
pulisher
Dec 16, 2025

Top Premarket Decliners - marketscreener.com

Dec 16, 2025
pulisher
Dec 15, 2025

[S-3] Verrica Pharmaceuticals Inc. Shelf Registration Statement | VRCA SEC FilingForm S-3 - Stock Titan

Dec 15, 2025
pulisher
Dec 15, 2025

Verrica Pharmaceuticals Earnings Notes - Trefis

Dec 15, 2025
pulisher
Dec 12, 2025

Armistice Capital LLC Increases Stock Holdings in Verrica Pharmaceuticals Inc. $VRCA - Defense World

Dec 12, 2025
pulisher
Dec 09, 2025

Verrica’s $50 Million PIPE Deal Sparks Big Questions About Its Next Growth Phase - MSN

Dec 09, 2025
pulisher
Dec 09, 2025

Verrica Pharmaceuticals Inc. announced that it has received $50.067383 million in funding from BKB Growth Investments, LLC and other investors. - marketscreener.com

Dec 09, 2025
pulisher
Dec 05, 2025

How buybacks impact Verrica Pharmaceuticals Inc. stock value2025 Investor Takeaways & Daily Stock Trend Watchlist - Newser

Dec 05, 2025
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Kapitalisierung:     |  Volumen (24h):